Grifols GRFS
NASDAQ GRFS
$7.43 -0.07 (-1.00%)
As of: Oct 22, 2026 · 10:11 AM EDT

Grifols (GRFS) Curent Deferred Tax Liability (2022 - 2023)

Updated

Analysis

Grifols (GRFS) Curent Deferred Tax Liability (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn -
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn -
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn -
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn -
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn -
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn -
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn -
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn -
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn -
10 Grifols 5.04 Bn 1.38 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -26.91 Mn
Dec 31, 2022 -93.79 Mn
API Access

Grifols Curent Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=GRFS&period=max&api_key=YOUR_API_KEY